Participation of suicide gene extracellular vesicles in metastasis prevention

Area of Science:

• Oncology
• Gene Therapy
• Nanomedicine

Background:

• Distant metastases are a primary cause of cancer mortality.
• Extracellular vesicles (EVs) play a crucial role in metastasis and pre-metastatic niche formation.
• Current therapeutic strategies face challenges in effectively targeting metastatic disease.

Purpose of the Study:

• To explore the potential of suicide gene therapy mediated by extracellular vesicles (EVs) for treating cancer metastasis.
• To investigate the use of engineered EVs for pre-metastatic niche modification and metastasis prevention.

Main Methods:

• Developing suicide gene therapy using EVs derived from mesenchymal stem/stromal cells, tumor cells, and cancer-associated fibroblasts.
• Conjugating suicide genes with prodrugs for targeted delivery and intracellular activation within tumor cells.
• Evaluating the tumor-tropic nature and anti-cancer efficacy of these engineered EVs.

Main Results:

• Suicide gene EVs demonstrate tumor tropism and penetrate tumor cells effectively.
• Intracellular conversion of prodrugs by suicide gene EVs yields potent anti-cancer drugs.
• Engineered EVs show potential in modifying the pre-metastatic niche.

Conclusions:

• Suicide gene EVs represent a novel therapeutic approach for metastasis.
• This strategy holds promise for preventing cancer spread and improving patient outcomes.
• Further research into suicide gene EVs could revolutionize cancer treatment.